Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker
<p>Abstract</p> <p>Background</p> <p>Tumor-associated antigens are appreciated as diagnostic markers, but they have also prompted tremendous efforts to develop tumor-specific immunotherapy. A previously cloned tumor-associated antigen, EBAG9, was initially defined by re...
Main Authors: | Daniel Peter, Stein Harald, Lehmann Insa, Erdmann Bettina, Anagnostopoulos Ioannis, Reimer Tatiana A, Dörken Bernd, Rehm Armin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-05-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/5/47 |
Similar Items
-
The placental RCAS1 expression during stillbirth
by: Tetlak Tomasz, et al.
Published: (2005-06-01) -
Expression of RCAS1 Correlates with Urothelial Bladder Cancer Malignancy
by: Wojciech Jóźwicki, et al.
Published: (2015-02-01) -
The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration
by: Wicherek Lukasz, et al.
Published: (2006-03-01) -
The molecular mechanism of secondary infectioninterference of RCAS viruses
by: Nien-Pin Tsou, et al.
Published: (2012) -
Increased RCAS1 Expression Is Associated with Advanced Histopathological Stage and Poor Prognosis in Patients with Gastric Adenocarcinoma
by: Constantinos Giaginis, et al.
Published: (2013-01-01)